Crossmark

Efficacy and safety of adalimumab in pediatric patients with Crohn’s disease: A systematic review and meta-analysis

Published Online: 2023-12-29

Published Print: 2024-03

Authors

Chen, Bin

Zou, Zhuan

Zhang, Xiaoyan

Xiao, Dongqiong

Li, Xihong
License Information

Text and Data Mining valid from 2023-12-29

Version of Record valid from 2023-12-29
More Information

Article History

Received: 24 June 2023

Accepted: 18 December 2023

First Online: 29 December 2023

Declarations

:

: No ethical approval was required for this study as it was a systematic review.

: No informed consent was required.

: The authors declare no competing interests.

Document is current